Evidence map›Paper›PMID 23637229›Full record

ArticleThe Journal of biological chemistry2013

Regulation of Rad17 protein turnover unveils an impact of Rad17-APC cascade in breast carcinogenesis and treatment.

Zhuan Zhou, Chao Jing, Liyong Zhang, Fujita Takeo, Hyun Kim, Yi Huang, Zhihua Liu, Yong Wan

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhuan ZhouDepartment of Cell Biology, University of Pittsburgh School of Medicine and Hillman Cancer Center, Pittsburgh, Pennsylvania 15213, USA.
Chao Jing
Liyong Zhang
Fujita Takeo
Hyun Kim
Yi Huang
Zhihua Liu
Yong Wan

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Interplay between Cdh1/APC and Rad17 in DNA damage checkpoints and carcinogenesisR01CA154695 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WAN, YONG · 2011 to 2015
$1.5M
NCATS NIH HHS UL1 TR000005NCI NIH HHS R01 CA154695NCI NIH HHS R01CA154695
6 · The paper itself

Abstract

Aberrant regulation of DNA damage checkpoint function leads to genome instability that in turn can predispose cellular tissues to become cancerous. Previous works from us and others demonstrated the role of Rad17 in either activation or termination of DNA damage checkpoint function. In the current study, we have revealed the unexpected accumulation of Rad17 in various types of breast cancer cell lines as well as human breast cancer tissues. We observed that Rad17 protein turnover rate in breast epithelial cells is much faster than in breast cancer cells, where the turnover of Rad17 is regulated by the Cdh1/APC pathway. We further observed that Rad17-mediated checkpoint function is modulated by proteolysis. Stabilization of Rad17 disrupts cellular response to chemotherapeutic drug-induced DNA damage and enhances cellular transformation. In addition, manipulation of Rad17 by RNA interference or stabilization of Rad17 significantly sensitize breast cancer cell to various chemotherapeutic drugs. Our present results indicate the manipulation of Rad17 proteolysis could be a valuable approach to sensitize breast cancer cell to the chemotherapeutic treatment despite of the critical role in governing DNA damage response and cellular recovery from genotoxic stress.

Indexed as

Signal TransductionAnaphase-Promoting Complex-CyclosomeAntigens, CDAntineoplastic AgentsBreast NeoplasmsCadherinsCell Cycle CheckpointsCell Cycle ProteinsCell LineCell Line, TumorCell SurvivalCisplatinDNA DamageFemaleHEK293 CellsHumansAnaphase-Promoting Complex-CyclosomeAntigens, CDAntineoplastic AgentsCadherinsCDH1 protein, humanCell Cycle ProteinsCisplatinRad17 protein, humanUbiquitin-Protein Ligase ComplexesAPCCarcinogenesisChromosomes/non-histone Chromosomal ProteinsDNA Binding ProteinGenome InstabilityProtein DynamicsProtein StabilityProtein TurnoverRad17

Identifiers

PMID23637229
PMCPMC3689957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.